2 million antibody products . Find yours today
View products

2 matching Reversion Inducing Cysteine Rich Protein With Kazal Motifs antibodies for Bacteria from 22 suppliers

Top Reversion Inducing Cysteine Rich Protein With Kazal Motifs Antibodies

Supplier

ABclonal Technology

More Data A6718 Rabbit Anti-mRECK antibody, Polyclonal 200 ul Bac, Hu, Mo, Rb IHC-F, IHC-P, WB
mRECK antibody, A6718, ABclonal Technology, Western Blot image
WB

Biorbyt

More Data orb584264 Rabbit Anti-Reversion Inducing Cysteine Rich Protein With Kazal Motifs antibody, Polyclonal 100 ul Bac, Bv, Cn, GP, Hu, Mo, Po, Rt WB

Reversion Inducing Cysteine Rich Protein With Kazal Motifs information

Aliases

Reversion Inducing Cysteine Rich Protein With Kazal Motifs is also known as hRECK, mRECK, RECK, ST15

View 14 Matching ELISA Kits

2 matching Reversion Inducing Cysteine Rich Protein With Kazal Motifs antibodies for Bacteria after applying filters

Click each Reversion Inducing Cysteine Rich Protein With Kazal Motifs antibody that interests you to view the full Reversion Inducing Cysteine Rich Protein With Kazal Motifs antibody datasheet.
View only Reversion Inducing Cysteine Rich Protein With Kazal Motifs Monoclonal Antibodies or Reversion Inducing Cysteine Rich Protein With Kazal Motifs Polyclonal Antibodies

ABclonal Technology

More Data A6718 Rabbit Anti-mRECK antibody, Polyclonal
200 ul
Bac, Hu, Mo, Rb
IHC-F, IHC-P,
mRECK antibody, A6718, ABclonal Technology, Western Blot image WB

mRECK antibody, A6718, ABclonal Technology, Western Blot image
WB

Biorbyt

More Data orb584264 Rabbit Anti-Reversion Inducing Cysteine Rich Protein With Kazal Motifs antibody, Polyclonal
100 ul
Bac, Bv, Cn, GP, Hu, Mo, Po, Rt
WB





Related antibodies

Reversion Inducing Cysteine Rich Protein With Kazal Motifs antibodies are often published withAssociated citations
GAPDH4.8%
4.8%
MLX Interacting Protein4.8%
CD2 Molecule4.8%
Fibronectin 14.8%
Fas Ligand2.4%
Cyclin-dependent kinase inhibitor 2A, isoform 12.4%
Matrix Metallopeptidase 92.4%
Carbonic Anhydrase 92.4%
CD442.4%